Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Germany Active

<< Previous

Bullboard Posts

Next >>

Comment by PeterGon Sep 10, 2021 11:12am

100 Views

Post# 33839739

RE:RE:Germany Active

No, we do not know more than you. We are frustrated about this ridiculous performance. It's a shame what management is currently doing. It's just the problem that we haven't really a lever to ensure that the part time CEO is stepping back. I'm pretty sure that an announcement from Sirona about a CEO change would probably boost the share price.

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo